SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-007644
Filing Date
2020-05-13
Accepted
2020-05-13 10:59:15
Documents
7
Period of Report
2020-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k051320.htm 8-K 42364
2 EXHIBIT 3.1 ex31crdf051320.htm EX-3.1 29745
3 EXHIBIT 4.1 ex41crdf051320.htm EX-4.1 47453
4 EXHIBIT 10.1 ex101crdf053220.htm EX-10.1 84903
5 EXHIBIT 10.2 ex102crdf051320.htm EX-10.2 81435
6 EXHIBIT 99.1 ex991crdf051320.htm EX-99.1 19033
7 ex991crdf051320image1.gif GRAPHIC 18444
  Complete submission text file 0001628280-20-007644.txt   332042
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 20871565
SIC: 2836 Biological Products, (No Diagnostic Substances)